Colleen Rivard1, Kelly Casserly2, Mary Anderson2, Rachel Isaksson Vogel3, Deanna Teoh2. 1. Department of Obstetrics, Gynecology and Women's Health, University of Minnesota, Minneapolis, Minnesota. Electronic address: clrivard@umn.edu. 2. Department of Obstetrics, Gynecology and Women's Health, University of Minnesota, Minneapolis, Minnesota. 3. Biostatistics and Bioinformatics, Masonic Cancer Center, University of Minnesota, Minneapolis, Minnesota.
Abstract
STUDY OBJECTIVE: To determine the factors that allow for a safe outpatient robotic-assisted minimally invasive gynecologic oncology surgery procedure. DESIGN: Retrospective chart review (Canadian Task Force classification II-1). SETTING: University hospital. PATIENTS: All patients (140) undergoing robotic-assisted minimally invasive surgery with the gynecologic oncology service from January 1, 2013, to December 31, 2013. INTERVENTIONS: Risk factors for unsuccessful discharge within 23 hours of surgery and same-day discharge were assessed using logistic regression models. MEASUREMENTS AND MAIN RESULTS: All patients were initially scheduled for same-day discharge. The outpatient surgery group was defined by discharge within 23 hours of the surgery end time, and a same-day surgery subgroup was defined by discharge before midnight on the day of surgery. One hundred fifteen (82.1%) were successfully discharged within 23 hours of surgery, and 90 (64.3%) were discharged the same day. The median hospital stay was 5.3 hours (range, 1-48 hours). Unsuccessful discharge within 23 hours was associated with a preoperative diagnosis of lung disease and intraoperative complications; unsuccessful same-day discharge was associated with older age and later surgery end time. Only 2 patients (1.4%) were readmitted to the hospital within 30 days of surgery. CONCLUSIONS: Outpatient robotic-assisted minimally invasive surgery is safe and feasible for most gynecologic oncology patients and appears to have a low readmission rate. Older age, preoperative lung disease, and later surgical end time were risk factors for prolonged hospital stay. These patients may benefit from preoperative measures to facilitate earlier discharge.
STUDY OBJECTIVE: To determine the factors that allow for a safe outpatient robotic-assisted minimally invasive gynecologic oncology surgery procedure. DESIGN: Retrospective chart review (Canadian Task Force classification II-1). SETTING: University hospital. PATIENTS: All patients (140) undergoing robotic-assisted minimally invasive surgery with the gynecologic oncology service from January 1, 2013, to December 31, 2013. INTERVENTIONS: Risk factors for unsuccessful discharge within 23 hours of surgery and same-day discharge were assessed using logistic regression models. MEASUREMENTS AND MAIN RESULTS: All patients were initially scheduled for same-day discharge. The outpatient surgery group was defined by discharge within 23 hours of the surgery end time, and a same-day surgery subgroup was defined by discharge before midnight on the day of surgery. One hundred fifteen (82.1%) were successfully discharged within 23 hours of surgery, and 90 (64.3%) were discharged the same day. The median hospital stay was 5.3 hours (range, 1-48 hours). Unsuccessful discharge within 23 hours was associated with a preoperative diagnosis of lung disease and intraoperative complications; unsuccessful same-day discharge was associated with older age and later surgery end time. Only 2 patients (1.4%) were readmitted to the hospital within 30 days of surgery. CONCLUSIONS:Outpatient robotic-assisted minimally invasive surgery is safe and feasible for most gynecologic oncology patients and appears to have a low readmission rate. Older age, preoperative lung disease, and later surgical end time were risk factors for prolonged hospital stay. These patients may benefit from preoperative measures to facilitate earlier discharge.
Authors: Giorgia Gaia; Robert W Holloway; Luigi Santoro; Sarfraz Ahmad; Elena Di Silverio; Arsenio Spinillo Journal: Obstet Gynecol Date: 2010-12 Impact factor: 7.661
Authors: Pamela T Soliman; Michael Frumovitz; Charlotte C Sun; Ricardo Dos Reis; Kathleen M Schmeler; Alpa M Nick; Shannon N Westin; Jubilee Brown; Charles F Levenback; Pedro T Ramirez Journal: Gynecol Oncol Date: 2011-08-27 Impact factor: 5.482
Authors: Maria B Schiavone; Thomas J Herzog; Cande V Ananth; Elizabeth T Wilde; Sharyn N Lewin; William M Burke; Yu-Shiang Lu; Alfred I Neugut; Dawn L Hershman; Jason D Wright Journal: Am J Obstet Gynecol Date: 2012-09-17 Impact factor: 8.661
Authors: John F Boggess; Paola A Gehrig; Leigh Cantrell; Aaron Shafer; Mildred Ridgway; Elizabeth N Skinner; Wesley C Fowler Journal: Am J Obstet Gynecol Date: 2008-10 Impact factor: 8.661
Authors: Joan L Walker; Marion R Piedmonte; Nick M Spirtos; Scott M Eisenkop; John B Schlaerth; Robert S Mannel; Gregory Spiegel; Richard Barakat; Michael L Pearl; Sudarshan K Sharma Journal: J Clin Oncol Date: 2009-10-05 Impact factor: 44.544
Authors: Victoria A Diedrichs; Jennifer P Lundine; Deena Schwen Blackett; Alexandra Zezinka Durfee; Xueliang Jeff Pan; Stacy M Harnish Journal: Neuropsychol Rehabil Date: 2022-03-14 Impact factor: 2.928